INTERNATIONAL PATENT: BLUEPRINT MEDICINES CORPORATION FILES APPLICATION FOR "EGFR INHIBITORS"

GENEVA, April 21 -- BLUEPRINT MEDICINES CORPORATION (45 Sidney StreetCambridge, MA 02139) filed a patent application (PCT/US2024/050695) for "EGFR INHIBITORS" on Oct 10, 2024. With publication no. WO/2025/080784, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AHMAD, Omar (c/o Blueprint Medicines Corporation45 Sidney StreetCambridge, MA 02139), BARVIAN, Kevin K. (c/o Blueprint Medicines Corporation45 Sidney StreetCambridge, MA 02139), CAMPBELL, John Emmerson (c/o Blueprint Medicines Corporation45 Sidney StreetCambridge, M...